Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat

作者: Jorge L. Poo , Gerard Feldmann , Serge Erlinger , Alain Braillon , Christophe Gaudin

DOI: 10.1016/0016-5085(92)91739-Q

关键词:

摘要: Abstract Chronic administration of ursodeoxycholic acid (UDCA) has recently been suggested as a potential treatment for cholestatic liver disease. The purpose this study was to examine the effects chronic oral UDCA on histological, biochemical, and hemodynamic abnormalities induced by bile duct ligation in rat. Fifty-one rats with ligation-section common were randomly blindly assigned receive (25 mg/kg each day) or placebo gavage 4 weeks. At end period, morphometric analysis showed that treated UDCA, hepatocyte sinusoidal volume fractions significantly higher than receiving [41.9 ± 3.2% vs. 28.1 1.8%, (mean SE) 7.4 0.1% 4.3 0.3%, respectively], whereas fraction (reflecting ductular proliferation) connective tissue lower (14,2 1.5% 20.0 1.0% 35.4 2.4% 47.6 1.7%, respectively). Serum aminotransferase alkaline phosphatase activities, total serum acids individual concentrations not different between two groups. Portal pressure (12.7 0.5 mm Hg 17.1 Hg), portal tributary blood flow (5.7 0.4 9.3 mL · min −1 100 g body weight), cardiac index (41.1 1.8 50.6 1.4 weight) UDCA-treated placebo-treated animals. In vein stenosed rats, had no effects, finding suggests direct vasoactive effect splanchnic circulation. It is concluded limits severity disease consequently hypertension hyperkinetic

参考文章(33)
J. Kountouras, P. J. Scheuer, B. H. Billing, Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. British journal of experimental pathology. ,vol. 65, pp. 305- 311 ,(1984)
Fenton Schaffner, Paolo G. Bacchin, Ferenc Hutterer, H. Herbert Scharnbeck, L. Laszlo Sarkozi, Helmut Denk, Hans Popper, Mechanism of Cholestasis: 4. Structural and biochemical changes in the liver and serum in rats after bile duct ligation Gastroenterology. ,vol. 60, pp. 888- 897 ,(1971) , 10.1016/S0016-5085(71)80089-6
M. Chojkier, R. J. Groszmann, Measurement of portal–systemic shunting in the rat by using gamma-labeled microspheres American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 240, ,(1981) , 10.1152/AJPGI.1981.240.5.G371
B H Lauterburg, J Bircher, Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat. Journal of Pharmacology and Experimental Therapeutics. ,vol. 196, pp. 501- 509 ,(1976)
J Reichen, B Egger, N Ohara, T B Zeltner, T Zysset, A Zimmermann, Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis. Journal of Clinical Investigation. ,vol. 82, pp. 2069- 2076 ,(1988) , 10.1172/JCI113828
Kohji Miyazaki, Fumio Nakayama, Akitoshi Koga, Effect of Chenodeoxycholic and Ursodeoxycholic Acids on Isolated Adult Human Hepatocytes Digestive Diseases and Sciences. ,vol. 29, pp. 1123- 1130 ,(1984) , 10.1007/BF01317087
A. Ward, R.N. Brogden, R.C. Heel, T.M. Speight, G.S. Avery, Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy Drugs. ,vol. 27, pp. 95- 131 ,(1984) , 10.2165/00003495-198427020-00001
Olivier Chazouillères, Raoul Poupon, Jean-Pierre Capron, Etienne-Henry Metman, Daniel Dhumeaux, Michel Amouretti, Patrice Couzigou, Denis Labayle, Jean-Claude Trinchet, Ursodeoxycholic acid for primary sclerosing cholangitis. Journal of Hepatology. ,vol. 11, pp. 120- 123 ,(1990) , 10.1016/0168-8278(90)90281-U
Raoul Poupon, RenéeE. Poupon, Yvon Calmus, Yves Chrétien, François Ballet, François Darnis, IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS The Lancet. ,vol. 329, pp. 834- 836 ,(1987) , 10.1016/S0140-6736(87)91610-2